Citadel Advisors
SRTS icon

Citadel Advisors’s Sensus Healthcare SRTS Stock Holding History

Citadel Advisors’s Portfolio SRTS Stock Details SRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.1K Sell
14,600
-300
-2% -$1.33K ﹤0.01% 12344
2025
Q4 		$59.3K Sell
14,900
-3,800
-20% -$14.1K ﹤0.01% 11947
2025
Q3 		$58.7K Buy
+18,700
New +$73.4K ﹤0.01% 12115
2025
Q1 		– Sell
-3,800
Closed -$26.3K – 15512
2024
Q4 		$26.3K Buy
3,800
+1,700
+81% +$12.5K ﹤0.01% 12983
2024
Q3 		$12.2K Buy
2,100
+1,500
+250% +$9.11K ﹤0.01% 13119
2024
Q2 		$3.2K Sell
600
-1,600
-73% -$7.35K ﹤0.01% 13616
2024
Q1 		$8.36K Buy
+2,200
New +$7.97K ﹤0.01% 13558
2023
Q2 		– Sell
-7,000
Closed -$36.5K – 15193
2023
Q1 		$36.5K Sell
7,000
-22,400
-76% -$161K ﹤0.01% 12540
2022
Q4 		$218K Sell
29,400
-24,700
-46% -$223K ﹤0.01% 9961
2022
Q3 		$678K Buy
54,100
+15,900
+42% +$190K ﹤0.01% 7808
2022
Q2 		$293K Sell
38,200
-13,300
-26% -$112K ﹤0.01% 9857
2022
Q1 		$521K Buy
+51,500
New +$470K ﹤0.01% 9287

Other funds holding SRTS

PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
GWM
Greenline Wealth Management Boca Raton, Florida $86.7M AUM

Citadel Advisors's SRTS Position: Q1 2026 in Review

Citadel Advisors sold out of Sensus Healthcare (SRTS) in Q1 2026, closing a stake of 33,459 shares — an estimated $149K sold.

Citadel Advisors first reported a position in SRTS in Q1 2021 and held it in 12 quarters. The position peaked at $1.36M in Q4 2024. 41 funds tracked by Wall St. Rank hold SRTS as of Q1 2026.

  • Citadel Advisors reported no remaining Sensus Healthcare position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 33,459 Sensus Healthcare shares in Q1 2026, an estimated $149K.
  • Citadel Advisors first reported a position in Sensus Healthcare in Q1 2021 and held it in 12 quarters.
  • Citadel Advisors's Sensus Healthcare position peaked at $1.36M in Q4 2024.
  • 41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.